Stay updated on Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma

Sign up to get notified when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:28:11.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision identifier updates from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:34:39.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The study page for the trial now displays a 403 Forbidden error, removing the previous study content and contacts and leaving only site chrome and the error message.
    Difference
    20%
    Check dated 2026-09-23T00:55:05.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.6.6 to v3.7.0, indicating a CMS update; no study text or page content appears to be affected.
    Difference
    0.1%
    Check dated 2026-09-15T23:49:34.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    An updated site revision tag (v3.6.6) replaces the previous version (v3.6.5), signaling a minor maintenance update to the page without altering study details.
    Difference
    0.1%
    Check dated 2026-09-01T19:45:11.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.5, replacing v3.6.4. This indicates a new software release version for the site rather than a change to study details.
    Difference
    0.1%
    Check dated 2026-08-11T15:28:13.000Z thumbnail image

Stay in the know with updates to Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.